Dynavax Technologies Corporation (DVAX)

Exchange
NASDAQ
Symbol
DVAX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company is headquartered in Emeryville, California.
Country
USA

Stock price

At close: September 5, 2025

  • Open
    9.98
  • High
    10.09
  • Low
    9.90
  • Close
    10.06
  • Volume
    1,421,970

Financial ratios

Dec 31, 2024